Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 87 (3), 458-9

Correlation of Smad4 Status With Outcomes in Patients Receiving Erlotinib Combined With Adjuvant Chemoradiation and Chemotherapy After Resection for Pancreatic Adenocarcinoma

Affiliations

Correlation of Smad4 Status With Outcomes in Patients Receiving Erlotinib Combined With Adjuvant Chemoradiation and Chemotherapy After Resection for Pancreatic Adenocarcinoma

Joseph M Herman et al. Int J Radiat Oncol Biol Phys.

Conflict of interest statement

Conflict of interest: none.

Similar articles

See all similar articles

Cited by 9 articles

See all "Cited by" articles

Publication types

MeSH terms

Feedback